Evidence map›Paper›PMID 31969184›Full record

ArticleBreast cancer research : BCR2020

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.

Samuel A Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde, James M Orcutt, Marina E Cazzaniga, Fanny Piette, Silvia Antolín, Elena Aguirre and 16 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Breast cancer research : BCR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 6 countries.

Samuel A JacobsNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. samuel.jacobs@nsabp.org.
André RobidouxNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Jame AbrahamNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
José Manuel Pérez-GarciaQuironSalud Group, IOB Institute of Oncology, Barcelona, Madrid, Spain.
Nicla La VerdePresent address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy.
James M OrcuttNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Marina E CazzanigaMedica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Fanny PietteInternational Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.
Silvia AntolínHospital Universitario, Coruña, Spain.
Elena AguirreMedica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Javier CortesQuironSalud Group, IOB Institute of Oncology, Barcelona, Madrid, Spain.
Antonio Llombart-CussacMedica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Serena Di CosimoMedica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Rim S KimNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Huichen FengNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Corey LipchikNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Peter C LucasNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Ashok SrinivasanNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Ying WangNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Nan SongNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Patrick G GavinNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
April D BalousekNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Soonmyung PaikNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Carmen J AllegraDepartment of Medicine, University of Florida Health, Gainsville, FL, USA.
Norman WolmarkNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Katherine L Pogue-GeileNSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
NSABP Foundation · USHospital Quirónsalud Barcelona · ESMedSIR (Spain) · ESASST Fatebenefratelli Sacco · ITAzienda Ospedaliera San Gerardo · ITCentre Hospitalier de l’Université de Montréal · CAComplexo Hospitalario Universitario A Coruña · ESFondazione IRCCS Istituto Nazionale dei Tumori · ITInternational Drug Development Institute (Belgium) · BEUniversity of Florida Health · USUniversity of Pittsburgh · USYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of this work [1] the authors have reported that in Table 3 The letter "T" in columns 5 and 7 should not be there.

Identifiers

PMID31969184
PMCPMC6975067
OpenAlexW2994601580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.